Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05104502 · ClinicalTrials.gov registry record · NA

Immunomodulatory Effects of Fasting in Healthy Adults

A NA study of Fasting, sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
4
Enrollment target
1
Study location

NCT05104502: Recruiting NA study of Fasting, sponsored by University of California, Davis.

NCT05104502 is a NA study of Fasting that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 4 participants, below the 209-participant average among 8 other Fasting trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05104502, a NA study of Fasting, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
4 participants
Enrollment target
1
Study location

Study Summary

This is a clinical trial assessing the effects of fasting on the immune system in healthy adults. Immune profiling, gene expression profiling, and flow cytometry on peripheral blood mononuclear cells (PBMCs) will be performed and we hypothesize that a period of fasting will alter the immune system in healthy adults.

Primary Outcome

Changes in surface proteins and glycoproteins of peripheral blood mononuclear cells

Conditions Studied

Interventions

  • BEHAVIORAL Dietary Fasting

Study Locations (1)

California

  • UC Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2022-03-25
Est. Completion 2026-06
Phase NA
University of California, Davis

657 total trials

What NCT05104502 shows while recruiting

NCT05104502 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 209-participant average among 8 other Fasting trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Fasting appearing as the primary indexed condition, and to 1 intervention - of which Dietary Fasting is the first listed.

NCT05104502 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05104502 about?

NCT05104502 is a clinical study titled "Immunomodulatory Effects of Fasting in Healthy Adults". This is a clinical trial assessing the effects of fasting on the immune system in healthy adults. Immune profiling, gene expression profiling, and flow cytometry on peripheral blood mononuclear cells (PBMCs) will be performed and we hypothesize that a period of fasting will alter the immune system i...

What is the current status of trial NCT05104502?

This trial is currently recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2022-03-25. Estimated completion is 2026-06.

What conditions does trial NCT05104502 study?

This clinical trial studies the following conditions: Fasting.

What interventions are being tested in trial NCT05104502?

The interventions under investigation include: Dietary Fasting (BEHAVIORAL).

Who is sponsoring clinical trial NCT05104502?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05104502 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fasting

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05104502's enrollment target sits among peer trials

4 9th of 8 the lowest of 8 other Fasting trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Fasting trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05104502, the US trial registry maintained by the National Library of Medicine. NCT05104502 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.